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Transcription factor activity and turnover are func-
tionally linked, but the global patterns by which
DNA-bound regulators are eliminated remain poorly
understood. We established an assay to define the
chromosomal location of DNA-associated proteins
that are slated for degradation by the ubiquitin-pro-
teasome system. The genome-wide map described
here ties proteolysis in mammalian cells to active
enhancers and to promoters of specific gene fam-
ilies. Nuclear-encodedmitochondrial genes in partic-
ular correlate with protein elimination, which posi-
tively affects their transcription. We show that the
nuclear receptor corepressor NCoR1 is a key target
of proteolysis and physically interacts with the tran-
scription factor CREB. Proteasome inhibition stabi-
lizes NCoR1 in a site-specific manner and restrains
mitochondrial activity by repressing CREB-sensitive
genes. In conclusion, this functional map of nuclear
proteolysis links chromatin architecture with local
protein stability and identifies proteolytic derepres-
sion as highly dynamic in regulating the transcription
of genes involved in energy metabolism.
INTRODUCTION
Ever-finer maps are being drawn of DNA and its occupying
transcriptional regulators and chromatin. This map is static by
default and only describes the constellation of proteins and
nucleic acids at a given time. However, many transcription
factors are short-lived and selectively destroyed by the ubiqui-
tin-proteasome system (UPS) upon assembly into functional
DNA-bound complexes (Salghetti et al., 2000). Such proteolysis
can have several consequences for gene expression. Simplified,1380 Cell 155, 1380–1395, December 5, 2013 ª2013 Elsevier Inc.it can restrict transcription by eliminating necessary factors, or it
can increase expression by removing repressors (Lipford and
Deshaies, 2003).
The quantitative contribution of local protein degradation on
individual gene expression has not been evaluated on a
genome-wide scale. We therefore sought to draw a dynamic
map of protein turnover to assess how DNA-associated pro-
teolysis correlates with specific genes and with chromatin
composition. Our study had three goals. The first goal was to
assess degradation of DNA-bound factors on a genome-wide
scale. The second goal was to define sites of proteolysis in the
context of gene expression and chromatin architecture. The third
goal was to identify transcriptional regulators with high turnover
dynamics and determine the impact of their degradation on rele-
vant gene transcription.
The UPS eliminates proteins in a specific, step-wise manner
(Ciechanover, 2012). Studies in S. cerevisiae demonstrated
that the UPS regulates transcription and showed by chromatin
immunoprecipitation (ChIP) that the proteasome physically
interacts with DNA (Auld et al., 2006). A caveat of this approach
is that some components of the proteasome regulate gene
expression without involving protein turnover. Furthermore, the
residence of the proteasome does not necessarily correspond
with the location at which the ‘‘kiss of death,’’ the conjugation
of ubiquitin chains, occurs. Other approaches to investigate
effects of the UPS on gene expression involve the identification
of target proteins bymass spectroscopy or the selective study of
enzymes involved in ubiquitin transfer, in particular E3 ubiquitin
ligases (Rubenstein and Hochstrasser, 2010). Importantly, these
studies do not provide spatial information such as the DNA bind-
ing pattern of target proteins at the time of degradation. We
therefore chose to directly examine the genomic sites of protein
elimination. The distribution of proteasome-sensitive ubiquitin
on DNA was used as an indicator of degradation initiation. By
charting the nuclear locations of proteolysis and functionally link-
ing proteasome activity to gene expression, we generated a
genome-wide map of DNA-associated proteolysis.
This project revealed a correlation of DNA-bound protein
degradation with active gene promoters and enhancers in
mouse and human cells. In addition, proteolysis was associated
with distinct gene ontologies and either promoted or suppressed
transcription. Nuclear-encoded mitochondrial genes in partic-
ular showed signs of rapid protein turnover, which stimulated
their expression. Utilizing integrative genomics, we identified
the nuclear receptor corepressor NCoR1 as a major target of
the UPS at these genes. Further, we defined biochemical inter-
action between NCoR1 and the transcription factor cyclic AMP
response element-binding protein (CREB) at degradation sites.
We therefore conclude that continuous elimination of NCoR1 is
required to maintain transcript levels, and restraining its turnover
by proteasome inhibition or depletion of the relevant ubiquitin
ligase Siah2 diminishes mitochondrial function.
RESULTS
A Method to Detect DNA-Associated Protein
Degradation
Ubiquitin not only marks proteins for degradation but is also
involved in nonproteolytic functions—for instance, ubiquitin
modifies histones H2A and H2B. Recent work suggests that
the composition of ubiquitin chains on proteolytic substrates is
variable (Xu et al., 2009), which makes it difficult to predict
what type of chain induces degradation. We therefore defined
degradative ubiquitination functionally by virtue of being sensi-
tive to proteasome inhibition. Exposing cells to a brief pulse of
the irreversible and specific inhibitor lactacystin leads to accu-
mulation of degradation-prone substrates in their polyubiquiti-
nated state. Such treatment results in a rapid redistribution of
ubiquitin from its nonproteolytic to a proteasome-targeting
function (Kim et al., 2011b). In particular, levels of monomeric
ubiquitin on histones H2A and H2B decrease to be channeled
toward the formation of degradative chains on proteins that
are slated for elimination (Figure 1A and data not shown). For
this study, we crosslinked and immunoprecipitated ubiquitin
with DNA in the presence or absence of proteasome inhibition
and mapped its location by sequencing. We defined genomic
sites at which degradation was initiated by comparing the
distribution of ubiquitin under proteolytic stress with that at
steady state.
Ubiquitin was tagged with an N-terminal 3FLAG epitope and
displayed no signs of toxicity. Furthermore, tagged ubiquitin
was a competent covalent modifier and distributed normally
(Figure 1B, left, and Figure 1C). Upon proteasome inhibition,
ubiquitin accumulated at degradation-prone substrates,
whereas its unconjugated form decreased (Figure 1B, left, red
arrow) (Kim et al., 2011b; Wagner et al., 2011). Treatment
also reduced the levels of monoubiquitination at histone H2A,
which is consistent with the expected redistribution (Figure 1B,
right, red arrow). Ubiquitin is an 8.6 kDa molecule that can
easily enter the nucleus. Given its abundance, we were con-
cerned that crosslinking of free ubiquitin with DNA could lead
to high background. To address this, we performed ChIP-
qPCR analyses with a dysfunctional ubiquitin mutant lacking
the C-terminal G76. Nonspecific crosslinking was responsible
for less than 2% of the specific DNA recovery achieved withfunctional ubiquitin (Figure 1D and data not shown). Asso-
ciation of DNA with ubiquitin is therefore mostly dependent
upon DNA binding of modified proteins and not of ubiquitin
itself. We treated cells with proteasome inhibitor or with
DMSO as solvent control (referred to as ‘‘untreated’’) for short
periods to minimize secondary effects. Treatment for 3 to
6 hr showed comparable results in ChIP experiments (data
not shown). This duration did not significantly affect the intra-
cellular location of ubiquitin, the viability and phenotype of
the cells in our study, or their cell-cycle distribution (Figures
S1A–S1D available online).
Degradative Ubiquitination Correlates with Active
Genomic Regions
Our next goal was to identify ubiquitination sites on a global
level in the presence of active or inactivated proteasome. We
performed ChIP-on-chip experiments with 3FLAG-ubiquitin
transduced human HEK293T cells and with human mesen-
chymal progenitor cells derived from the H9 embryonic stem
cell line (Figure S2A). Inspecting 24,633 promoters, there was
substantial overlap in ubiquitin-associated promoters between
lactacystin-treated and untreated cells (58.3% for HEK293T
cells and 34.1% and 40.8% for two independent experiments
with H9-derived mesenchymal cells; Figure S2B). However,
genes of promoters that were exclusively associated with
degradative ubiquitination in the treated sample were more
highly expressed than those that were uniquely linked to
steady-state ubiquitination (p = 0.000878 for HEK293T cells
and p = 3.2 3 108 for H9-derived cells; two-sided Wilcoxon
rank-sum test; Figure S2C). These findings connect degradation
with high transcription levels and are consistent with data in
S. cerevisiae, in which DNA binding of the proteasome correlates
with active genomic regions (Auld et al., 2006).
In order to create an unbiased genome-wide map of DNA-
linked degradation, we combined ChIP with next-generation
sequencing (ChIP-seq). We analyzed the well-established
mouse preadipocyte cell line 3T3-L1 in its undifferentiated
form, a cell type that may be described as analogous to the
human H9-derived mesenchymal cells. 3T3-L1 cells are widely
used to study adipogenesis and metabolism in vitro. Several
groups have mapped the genome of 3T3-L1 cells, and global
chromatin profiles are available (Mikkelsen et al., 2010). We
performed two independent experiments and analyzed a total
of 33,164 3FLAG-ubiquitin peaks with and 46,044 peaks without
addition of proteasome inhibitor. 36.6% of the ubiquitin peaks
overlapped between the two experiments with lactacystin
treatment, and 63.2% of peaks overlapped between the two
untreated experiments. This manuscript focuses on peaks that
were reproducible within their respective treatment condition
between both experiments. An analysis of all peaks produced
similar results (data not shown).
To assess the regulatory relationship between degradation
and transcript levels, we evaluated the expression of genes
whose transcription start sites (TSS) are located within 3 kilo-
bases of ubiquitin peaks. We observed a tight connection be-
tween proteasome-sensitive ubiquitination and active gene
expression (Figures 2A, 2B, and S2D; p = 1.95 3 10142; two-
sided Wilcoxon rank-sum test with Bonferroni correction).Cell 155, 1380–1395, December 5, 2013 ª2013 Elsevier Inc. 1381
Figure 1. Ubiquitin Redistributes following Proteasome Inhibition
(A) Top: polyubiquitination (Ub, green circles) initiates degradation. Bottom: proteasome inhibition (yellow rhombus) increases ubiquitination on elimination-prone
substrates, whereas nondegradative ubiquitination, e.g., on histones (H2), remains unaffected or even decreases.
(B) Left: immunoblotting (IB) of 3FLAG-ubiquitin after proteasome inhibition for up to 3 hr (25 mM lactacystin) in HEK293T cells. Ubiquitin conjugation increases up
to 80%, whereas free ubiquitin decreases (red arrow). Nonfunctional ubiquitin (D76) fails to modify proteins (right lanes). Right: monoubiquitination of 3FLAG-H2A
decreases upon treatment (red arrow), quantified by densitometry (bottom).
(C) The 3FLAG epitope does not interfere with the distribution of tagged proteins in HEK293T cells by immunohistochemistry (red for FLAG epitope; nuclei in blue).
(D) ChIP-qPCR of HEK293T cells after transfection with 3FLAG-H2A (positive control), 3FLAG-ubiquitin, or 3FLAG-ubiquitin(D76). Recovery of crosslinked DNA is
60-fold reduced in mutant compared to wild-type ubiquitin (probed for GAPHD promoter). Bars represent mean ± SD.
See also Figure S1.We next investigated whether ubiquitin peaks cluster in re-
gions relevant for transcription. To this purpose, we depicted
the metagenomic changes in ubiquitination following protea-
some inhibition. Treatment produced signal enrichments imme-
diately upstream of the TSS (Figures 2C and S3A), implying that
the promoters of active genes are sites of vigorous protein turn-
over. Differential analysis also suggests that steady-state ubiqui-
tination is more prevalent over the gene body. To more precisely
correlate the location of ubiquitinated substrates with chromatin
architecture, we compared our binding sites with a map of
histone H3 modifications (Mikkelsen et al., 2010). Steady-state
ubiquitination frequently occurred at regions that are trimethy-
lated at H3K27 (Figure 2D, left), which is considered a repressive
modification (Kouzarides, 2007). Following treatment with lacta-
cystin, we observed a redistribution of ubiquitin toward active
histone marks, including acetylated H3K27 and methylated1382 Cell 155, 1380–1395, December 5, 2013 ª2013 Elsevier Inc.H3K4 (Figures 2D, right, and Figures S3B and S3C). The majority
of ubiquitination sites overlapped with at least one of the six H3
chromatin states studied (83.4% in untreated and 96.9% in
treated cells).
Proteasomes have been observed to cluster with polyubiqui-
tinated proteins in the cytoplasm. This attraction is promoted
by ubiquitin-binding proteins such as S5a, which are located
in the lid subunits (Sakata et al., 2012). The lids are noncovalently
associated with the core of the proteasome that contains
the catalytic subunits. To test whether proteasome and sub-
strate also colocalize in the nucleus, we performed ChIP-seq
with a 3FLAG-tagged version of the catalytic proteasome
subunit b1 (PSMB1). The N-terminal tag did not interfere
with integration into the holoproteasome, as assessed by coim-
munoprecipitation and immunoblots (Figure 2E). Also, previous
studies showed that inhibitors do not dissociate the
holoenzyme and that the majority of proteasomes are fully
assembled when bound to DNA (Geng and Tansey, 2012;
Kriegenburg et al., 2008). Based on ChIP-seq, location of the
proteasomemirrored ubiquitination sites, including a remarkable
redistribution following lactacystin treatment. At steady state,
the proteasome remained in genomic regions rich in trimethy-
lated H3K27 (Figure 2F, left). After inhibition, we observed
increased clustering with active markers, including methylated
H3K4 and acetylated H3K27 (Figure 2F, right). This further vali-
dated our assay by showing that lactacystin treatment and the
accumulation of ubiquitin on degradation-prone substrates is
followed by an equivalent mobilization of the proteasome to
such affected genomic regions.
The complexity of gene expression in metazoans is thought to
be largely driven by enhancer elements. Given the variable
genomic distance between enhancers and their target genes,
functional annotations have been notoriously difficult. However,
it was recently proposed that these DNA elements can be
defined by a distinct combination of chromatin signatures.
Enhancers and promoters generally display H3K4 mono- or
trimethylation, respectively, and by considering the status of
H3K27 acetylation versus methylation, active and inactive
regions can be distinguished (Heintzman et al., 2009). We deter-
mined the relative enrichment of degradative ubiquitination and
found strong correlations with both active enhancers and active
promoters (Figure 2G; p = 8.17 3 10318 and p = 8.36 3 10319,
respectively; two-sided Fisher’s exact test).
Taken together, our data suggest that protein turnover mirrors
gene activity. Degradation is linked to specific chromatin states
and is enriched at regulatory sites.
Site-Specific Degradation Promotes Expression of
CREB Target Genes
Our next goal was to investigate the functional impact of local
degradation on target gene expression. To minimize secondary
effects on genes that are downstream of proteasome-sensitive
signaling pathways, the shortest effective treatment duration
for lactacystin was used. Although a 3 hr regimen was sufficient
to observe redistribution of ubiquitin by ChIP, we had to extend
this treatment to 6 hr for significant changes to transpire in overall
gene expression. Extension of the lactacystin pulse increased
the log2-normalized gene expression variance by 5.1-fold (Fig-
ure 3A). We previously noted that degradation peaks correlate
with enhancer sequences. However, rapid changes in gene
expression upon proteasome inhibition were more common
when protein turnover was located close to TSS and were likely
promoter associated (Figure 3B).
To define target genes of local proteolysis, degradation peaks
that were within 3 kilobases of TSS were selected, and the
sensitivity of these genes to 6 hr of lactacystin treatment was
assessed. Compared to the entire genome (data not shown) or
to steady-state ubiquitination sites (Figure 3C, blue curve),
degradation-associated genes were overall repressed by pro-
teasome inhibition (Figure 3C, red curve and arrow, and Fig-
ure S3D; p = 4.683 1026). In other words, protein turnover close
to TSS has a positive effect on the expression of a significant
fraction of genes. A possible bias could be introduced if lacta-
cystin had a generally toxic effect on gene expression, whichwould disproportionally affect short-lived messenger RNAs
(mRNAs). However, this was not the case, as degradation-asso-
ciated transcripts were of average half-life (Figure S3E) (Schwan-
ha¨usser et al., 2011). Instead, the products of these genes were
significantly enriched for certain ontologies (Figures 3D and
S3F), including nuclear-encoded mitochondrial components,
ribosomes, and other RNA-interacting proteins, cell-cycle regu-
lators, and nucleosome subunits (Figure S3G).
The ultimate goal of this topographical analysis is to identify
the DNA-bound proteins that are targeted for degradation. By
scanning sites of proteasome-dependent ubiquitination for
known transcription factor binding motifs, we found enrichment
of several DNAmotifs, the top five ofwhich are shown (Figure 3E).
Utilizing a metric based on the significance of motif occurrence,
the expression level of the transcription factor in question, and
the quality of the observed DNA sequence motif, we picked
c-Jun and CREB as the most promising candidates for being
degraded at high levels. Within the regions scanned, we found
more than 2,000 occurrences of the c-Jun binding sequence
and more than 4,000 hits for CREB with excellent conservation
of the observed motifs (Figure 3F). To directly assess any
connection between these two transcription factors and degra-
dation sites, ChIP-seq for endogenous CREB and for 3FLAG-
c-Jun was performed. Whereas c-Jun preferentially bound to
enhancer sequences, CREB was a more promoter-correlated
transcription factor (Figure 3G). Both factors were associated
with degradation sites (both p < 10317, Two-sided Fisher’s
exact test), with the relative enrichment of CREB outperforming
that of c-Jun by 51.7% (Figure 3H). The DNA occupancy heat-
map underscored the superior overlap of CREB binding with
degradation sites compared to c-Jun (Figure 3I).
To investigate a functional link between CREB, c-Jun binding,
and protein turnover, we compared the lactacystin sensitivity
of genes within three kilobases of these transcription factors.
Several c-Jun target genes were upregulated following pro-
teasome inhibition (Figure 3J, gray curve and arrow). On the
other hand, a proportion of CREB target genes was downregu-
lated following lactacystin treatment (Figure 3J, black curve).
Nuclear-encoded mitochondrial genes were significantly en-
riched for CREB binding (p = 3.7 3 1040, Fisher’s exact test),
and CREB was associated with 30.6% of all annotated nuclear
mitochondrial genes (390 out of 1,274) (Huang da et al., 2009).
Overall, CREB-linked genes were not significantly up- or down-
regulated by proteasome inhibition, but the mitochondrial frac-
tion was clearly repressed (Figure 3J, dotted curve and black
arrow; p = 6.12 3 106 comparing mitochondrial to nonmito-
chondrial CREB target genes).
Taken together, we showed that promoter-linked proteolysis
stimulates the transcription of a substantial number of genes
and, importantly, that these genes are enriched for certain func-
tional ontologies, with mitochondrial components being the
most prevalent. We could also demonstrate that subsets of
CREB target genes significantly correlate with protein turnover.
CREB and NCoR1 Interact at Particularly Proteasome-
Sensitive Genes
These results suggest that CREB elimination may be responsible
for several of the defined DNA-linked degradation peaks.Cell 155, 1380–1395, December 5, 2013 ª2013 Elsevier Inc. 1383
(legend on next page)
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However, the following lines of evidence argue against that infer-
ence. First, genome-wide binding of CREB showed no dramatic
change upon proteasome inhibition (Figures S4A–S4E and data
not shown). Second, CREB is considered an activating transcrip-
tion factor, especially at mitochondrial target genes (Altarejos
and Montminy, 2011). Thus, its stabilization should increase
the expression of relevant genes. We therefore examined
whether a CREB corepressor, rather than CREB itself, is stabi-
lized by proteasome inhibition. To identify a potential core-
pressor, we searched for DNA-binding motifs in regions where
CREB and degradation peaks overlapped. Among other motif
signatures, we found enrichment for ZBTB33, a protein that
lends its DNA-binding domain to the nuclear receptor core-
pressor NCoR1 (Figure 4A; p = 1.59 3 1012, Z test) (Yoon
et al., 2003). NCoR1 is a large adaptor module (271 kDa) that is
involved in silencing of nuclear receptor target genes and is a
known substrate of the UPS (Perissi et al., 2010). Conditional
NCoR1 knockout increases insulin sensitivity and mitochondrial
function by about 30% (Li et al., 2011; Yamamoto et al., 2011).
Given that proteasome inhibition repressed nuclear-encoded
mitochondrial genes and that these genes significantly over-
lapped with degradation sites (Figures 3C, 3D, and 3J), we in-
vestigated NCoR1 for mediating lactacystin-induced gene
repression. Re-examining the genome-wide map of NCoR1
binding sites in 3T3-L1 cells, published by others (Raghav
et al., 2012), revealed that NCoR1 preferentially bound to pro-
moters compared to enhancers, similar to CREB (Figure 4B,
left). Furthermore, NCoR1 binding sites correlated with de-
gradation peaks, especially when overlapping with CREB sites
(Figure 4B, right). 47.6% (1,749) of genes that were within 3 kilo-
bases of CREB were also within the same range of NCoR1 bind-
ing sites (Figure 4C). Of these, 23.2% (405) overlapped with
genes in range of degradation sites. Such triple-associated
genes were significantly repressed by proteasome inhibition
(Figure 4D; p = 4.54 3 105) and enriched for nuclear-encoded
mitochondrial genes (p = 0.00016, Fisher’s exact test).
Association does not prove interaction, and the promoters of
distinct cell fractions could be occupied by either NCoR1 or by
CREB in a mutually exclusive fashion. To investigate whether
these two factors biochemically interact, we performed nuclear
coimmunoprecipitation without crosslinking. The results demon-
strate that overexpressedNCoR1 andCREB can engage in com-
plex formation with each other (Figure 4E).Figure 2. Degradation Is Enriched at Highly Expressed Genes
(A) Log2-normalized expression values of genes with TSSwithin 3 kbp of ubiquitin
mock treated or treated with lactacystin. The first box plot depicts the expression
genes in untreated or lactacystin-treated cells (1,218 and 1,755 genes, respective
ubiquitin in untreated or treated cells (892 and 1,429 genes, respectively).
(B) Expression ranks of genes associated with ubiquitination. Considered were
Proteasome-sensitive ubiquitination is associated with higher transcription (p = 1
(C) Metagenomic change in ubiquitin distribution following lactacystin treatment
(D) Correlation of ubiquitin enrichment with chromatin marks in untreated and tre
modifications are shown.
(E) IB after IP of 3FLAG-PSMB1 in 3T3-L1 cells. 3F-PSMB1 expression was regu
(F) Regional overlaps of H3 chromatin marks with 3FLAG-PSMB1 ChIP-seq pea
(G) Enrichment of ubiquitin at active promoters (H3K4me3/H3K27ac) and enhan
ubiquitination is associated with active enhancers and promoters (p = 8.17 3 10
See also Figures S2 and S3.We next examined in more detail three randomly picked mito-
chondrial genes that were repressed by proteasome inhibition
and associated with degradation: AKAP1, MRPS18b, and
NDUFV1. ChIP-seq tracks at these three genes showed over-
lapping peaks between degradative ubiquitination, CREB, and
NCoR1 close to the TSS (Figure 4F). We confirmed co-occu-
pancy of endogenous NCoR1 and CREB at these promoters
by sequential ChIP (Figure 4G; p < 0.008, two-sided Student’s
t test).
NCoR1 is best known for its role in repressing unliganded
nuclear hormone receptors (Perissi et al., 2010). The interaction
with nuclear hormone receptors is mediated by NCoR1’s
C-terminal receptor interaction domains (RID). To address which
regions are involved in binding to CREB, we deleted all three
RIDs. This mutant form of NCoR1 still robustly interacted with
CREB (Figure 4H, third lane). On the other hand, deletion of the
kinase-inducible domain (KID) in CREB markedly reduced bind-
ing to NCoR1 (Figure 4H, fourth lane). The KID is required for full
activation of CREB via phosphorylation of S133, and its involve-
ment in NCoR1 binding suggests a link between transcriptional
activity and repression.
Taken together, our data argue for an interaction between
CREB and the corepressor NCoR1 at specific promoters. These
sites are concentrated at nuclear-encoded mitochondrial genes.
Their susceptibility to proteasome inhibition may reflect a
requirement for continuous corepressor degradation.
Proteolysis of NCoR1 by Siah2 Derepresses
Mitochondrial Genes
To verify functional consequence of the interaction between
CREB and NCoR1, we examined gene expression following
NCoR1 knockdown by RNA interference (for knockdown effi-
ciencies, see Figures S4F–S4H). Compared to the entire
genome, CREB target genes were significantly derepressed by
NCoR1 deletion (Figure 5A, black curve and arrow; p = 4.54 3
105). The subset of mitochondrial CREB targets showed a trend
for even stronger activation relative to all CREB-associated
genes (Figure 5A, dotted curve; p = 2.79 3 105; two-sided
Wilcoxon rank-sum test). As a control, c-Jun target genes were
not affected (Figures S4I and S4J). We also observed robust
upregulation of degradation-associated genes in the absence
of NCoR1 (data not shown; p = 6.99 3 1014), arguing for a
connection between local protein turnover and NCoR1.peaks. ChIP-seqwas performedwith 3FLAG-ubiquitin in 3T3-L1 cells that were
range of the entire genome. Next shown are the plots for ubiquitin-associated
ly). The two right-most plots depict genes that are exclusively associated with
892 genes unique to untreated cells and 1,429 genes unique to treated cells.
.95 3 10142).
(genes scaled to 3 kbp size). TSS and termination site are marked.
ated 3T3-L1 cells. Regional overlaps between ubiquitin peaks and histone H3
lated by a repressor (Tet).
ks.
cers (H3K4me1/H3K27ac) (bars represent mean ± SD). Proteasome-sensitive
318 and p = 8.36 3 10319).
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The nuclear proteolysis map presented here is unlikely to offer
a complete record of all DNA-associated degradation events.
Because our data suggest that continued transcription of some
mitochondrial genes requires protein turnover, we next exam-
ined the entire set of 1,274 annotated nuclear mitochondrial
genes and found strong derepression in NCoR1 knockdown
cells (Figure 5B, blue curve; p = 2.923 1011). This set of genes
was also downregulated by proteasome inhibition (data not
shown; p = 1.31 3 1057). Therefore, although our examination
of nuclear proteolysis only attributed degradation to 12.2% of
mitochondrial genes, it accurately defined these genes in
general as antagonistically regulated by NCoR1 and the
proteasome.
We next sought to determine whether NCoR1 itself is targeted
for degradation at these sites. Previous work has defined Siah2
as an E3 ligase that ubiquitinates NCoR1 for elimination (Zhang
et al., 1998). Cells that were depleted for NCoR1 (Figure 5B,
blue curve) showed higher expression of mitochondrial genes
compared to NCoR1/Siah2 double-knockdown cells (black
curve; p = 9.26 3 1037). Knockdown of Siah2 alone resulted
in repression of mitochondrial genes (Figure 5B, orange curve;
p = 6.33 3 1082). The response to depletion of NCoR1 versus
NCoR1 in combination with Siah2 did not apply to the entire
genome but significantly affected nuclear-encoded mitochon-
drial genes (Figure 5C; p = 7.24 3 1084). Ratios greater than
one on the x coordinate in Figure 5C indicate genes that are
either more upregulated or less downregulated in the single
compared to the double-knockdown cells.
To determine whether the observed antagonism between
NCoR1 and Siah2 was connected by the proteasome, we as-
sessed the sensitivity of mitochondrial genes in single versus
double-knockdown cells to proteasome inhibition. Although
both cell types repressed mitochondrial genes upon lactacystin
treatment, this response was attenuated in double-knockdown
cells. Increased resistance of mitochondrial genes to lactacystin
with Siah2 depletion resulted in an off-diagonal shift when
plotted against NCoR1 single-knockdown cells (Figure 5D; p =
9.53 3 104). The reduced dynamic range indicates a role of
Siah2 in proteasome-dependent derepression.
To substantiate our proposed model mechanistically, we
analyzed the promoters of the three mitochondrial genesFigure 3. DNA-Linked Proteolysis Impacts Specific Genes
(A) Log2-normalized genome-wide expression in untreated or lactacystin-treated
treatment.
(B) Sensitivity of genes to lactacystin (y axis) in relationship to distance of closes
(C) Response of genes to lactacystin treatment. Plotted are genes with TSS with
Proteasome inhibition represses some degradation-associated genes (red arrow
(D) Gene ontologies associated with degradative ubiquitination. Considered wer
(E) Motif enrichments in regions of degradative ubiquitination, expression ranks
(F) Motifs for CREB and c-Jun in regions of DNA-associated protein turnover.
(G) Enrichment of 3FLAG-c-Jun and endogenous CREB at active enhancers and
(H) Correlation of ubiquitin peaks and CREB and c-Jun binding. Bars represent m
(I) Heatmap of ubiquitination peaks (left), CREB (middle), and c-Jun (right) at 1,75
3 kbp up- and downstream.
(J) Response of the entire genome (green curve) or specific target genes to lacta
partially upregulated following proteasome inhibition (gray curve and arrow). C
significant for nuclear mitochondrial CREB targets (dotted curve and black arrow
See also Figure S3.AKAP1, MRPS18b, and NDUFV1. ChIP-qPCR confirmed DNA
binding (data not shown) and revealed that the levels of
NCoR1, but not CREB, increased following lactacystin treatment
(Figures 5E and S5A; p < 0.03, two-sided Student’s t test). In
agreement with our previous microarray-based results,
AKAP1, MRPS18b, and NDUFV1 were repressed by protea-
some inhibition (p < 0.032, two-sided Student’s t test), activated
upon NCoR1 depletion (p < 0.0015, two-sided Student’s t test),
and repressed by Siah2 knockdown (p < 0.03, two-sided
Student’s t test) but were not significantly affected by the com-
bined depletion of NCoR1 and Siah2 (Figure 5F). Proteasome in-
hibition also reduced expression in NCoR1 single-knockdown
cells, but the transcript levels after treatment were higher
compared to treated native or treated double-knockdown cells
(p < 0.01, two-sided Student’s t test). This residual effect may
be caused by the incomplete removal of NCoR1 by RNA interfer-
ence or by compensating factors. Consistent with a direct effect
of NCoR1 turnover on the expression of AKAP1,MRPS18b, and
NDUFV1, its promoter occupancy was significantly increased in
Siah2-depleted cells (Figure 5G; p < 0.014, two-sided Student’s
t test). To test whether this correlated with reduced levels of
ubiquitinated NCoR1 in the absence of Siah2, we performed
sequential ChIP-qPCR first for NCoR1 and then for polyubiquitin.
We observed the expected decrease in ubiquitinated NCoR1 at
these promoters, indicating that continuous ubiquitination and
degradation of NCoR1 occurs in a Siah2-mediated fashion
(Figure 5H; p < 0.013, two-sided Student’s t test). Concomi-
tantly, knockdown of NCoR1 was accompanied by a reduced
level of site-specific ubiquitination, suggesting that the core-
pressor is a major substrate of the UPS at these promoters (Fig-
ure S5B; p < 0.023, two-sided Student’s t test). We did not
observe such a decline of ubiquitin at genes that were unrespon-
sive to proteasome inhibition (data not shown).
We further validated the interaction between NCoR1 and
CREB by depleting CREB through small hairpin RNA (shRNA).
Many CREB target genes were upregulated in the absence of
specific stimulation (Figure 5I, blue curve; p = 9.42 3 1024).
This derepression was especially high at genes that were also
co-occupied by NCoR1 and degradation peaks (Figure 5I, red
curve; p = 0.0368 compared to all CREB target genes). We
also found strong positive correlation between the effects of3T3-L1 cells. Gray dots indicate 3 hr treatment, and black dots indicate 6 hr
t degradation site (x axis).
in 3 kbp of the closest steady state (blue) or degradative ubiquitin peak (red).
).
e 1,755 genes with ubiquitin peaks within 3 kbp of TSS.
of transcription factors, and quality of the observed motifs.
promoters.
ean ± SD.
5 promoters associated with degradation. Midlines represent TSS; shown are
cystin (targets defined by TSS within 3 kbp of binding sites). c-Jun targets are
REB-associated genes show a trend for downregulation (black curve) that is
; p = 6.12 3 106).
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NCoR1 and CREB knockdown on mitochondrial NCoR1 target
genes (407 genes, Figures S5C–S5F; p = 8.83 3 1024 by linear
regression; Pearson’s coefficient r = 0.4673). CREB occupancy
at the promoters of AKAP1, MRPS18b, and NDUFV1 was
reduced by >77% in knockdown cells (data not shown). On
the other hand, ChIP with an antibody against a region that is
shared between CREB, ATF-1, and CREM showed no difference
in CREB knockdown cells (data not shown). These observations
suggest that CREB-like proteins rescue expression of CREB
target genes in knockdown cells (Blendy et al., 1996) but fail to
compensate for corepressor recruitment (Figures 5J and 5K;
p < 0.04 and p < 0.05, two-sided Student’s t test).
Knockdown of NCoR1 or Siah2 had no effect on the phos-
phorylation level of CREB (Figure 5L), arguing that repression
is achieved downstream of CREB activation. Phosphorylated
CREB can recruit the histone acetyl transferase CBP/p330. To
examine a potential antagonism on the chromatin level between
the coactivator CBP/p300 and the HDAC-associated core-
pressor NCoR1 (You et al., 2013), we studied levels of H3K27
acetylation. This histonemodification was significantly increased
in the absence of NCoR1 and decreased in the absence of Siah2
(Figure 5M; p < 0.005, two-sided Student’s t test).
Combined, our results demonstrate that NCoR1 represses
CREB target genes and specifically nuclear mitochondrial genes
by deacetylating chromatin. This function is adjusted by the
continuous degradation of NCoR1, mediated by the E3 ubiquitin
ligase Siah2.
Dynamic Antagonism between NCoR1 and Siah2
Balances Mitochondrial Function
The conditional knockout of NCoR1 in muscle cells results in
20%–30% increased oxidative function (Yamamoto et al.,
2011). To formally prove that the expression changes in
NCoR1-depleted 3T3-L1 cells also translate into altered mito-
chondria function, we performed electrophysiological tests.
The potentiometric dye DiOC6(3) is a marker for mitochondrial
membrane potential (Dcm) (Perry et al., 2011). We analyzed cells
with unaltered gene expression or following depletion of NCoR1
alone or in combination with Siah2. NCoR1 knockdown did not
change the number of mitochondria based on fluorescent label-
ing or DNA quantification (Figures 6A, top, and S6A). However,
the Dcm increased following NCoR1 single but not Siah2/
NCoR1 double knockdown (Figure 6A, bottom, and FiguresFigure 4. CREB and Corepressor NCoR1 Interact at Proteasome-Sens
(A) Sites of CREB binding and overlapping degradation revealed enrichment of t
(B) Global distribution of NCoR1 favors binding at active promoters (left: sites defin
for degradation at NCoR1- and CREB-associated genes is 48.3% stronger than
mean ± SD.
(C) Venn diagram of genes with TSS within 3 kbp of NCoR1, CREB, and degrada
(D) Gene sensitivity to lactacystin treatment (bars represent mean ± SEM). Genes
are repressed by proteasome inhibition (p = 4.54 3 105).
(E) IB after IP of 3FLAG-NCoR1. 3F-NCoR1 expression in 3T3-L1 cells was cont
(F) ChIP-seq traces of degradative ubiquitination, CREB, and NCoR1 at three nu
(G) Sequential ChIP-qPCR was performed with isotype control, anti-NCoR1, and
in all three mitochondrial promoters (p < 0.008). Bars represent mean ± SD.
(H) IB after IP of 3FLAG-NCoR1 andHA-CREB transfected humanHEK293T cells.
lane three and C(DKID), a mutant lacking the KID domain of CREB, was used in
See also Figure S4.S6B and S6C; p < 0.04, two-sided Student’s t test). Conversely,
overexpression of NCoR1 by transfection or extended protea-
some inhibition reduced the Dcm (Figures S6D–S6F).
We verified the electrophysiological results with optical
ratiometric analyses using JC-1. This dye is an indicator of mito-
chondrial function and aggregates upon hyperpolarization, lead-
ing to a shift in fluorescence (Collins et al., 2002). Figure 6B
depicts the relative increase in J-aggregate formation in
NCoR1 knockdown cells. This shift was evident on a population
level as well as in the amount of aggregates found within individ-
ual hyperpolarized cells (Figure 6C).
Together, these functional tests confirm that NCoR1 and
Siah2 adversely influence mitochondrial membrane potential.
Stabilization of NCoR1 by proteasome inhibition or Siah2 knock-
down presumably reduces ATP production through oxidative
phosphorylation.
Synchronization betweenMitochondrial Activity and the
NCoR1/Siah2 Axis
Metabolic adaptation requires communication between mito-
chondria and the nucleus because the organelle only carries
13 protein-coding genes (Ryan and Hoogenraad, 2007). We
challenged mitochondria by depolarization with the uncoupling
ionophore FCCP and observed induction of mitochondrial genes
(Figure 7A, red gate, and S7A; p = 2.8 3 1020, Fisher’s exact
test). Genes that were stimulated by FCCP were repressed in
Siah2 knockdown cells (p < 4.51 3 10308 and p = 1.1 3 1037
for upregulation of CREB target genes by FCCP, data not
shown). We also observed the expected opposite effect of
FCCP and proteasome inhibition on mitochondrial genes
(Figure 7B; p = 6.31 3 1040 for repression by lactacystin, p =
3.91 3 104 for induction by FCCP, and there is no significant
effect for combined treatment). At least part of the activation
following depolarization was achieved by Siah2-dependent
removal of NCoR1 from target promoters (Figure 7C; p < 0.027
for removal following FCCP, and p < 0.01 for upregulation of
endogenous NCoR1 in Siah2 knockdown cells; two-sided
Student’s t test). Lack of Siah2 reduced the effect of FCCP on
gene induction (Figure 7D; p < 0.015, two-sided Student’s
t test). Siah2 itself was robustly upregulated by mitochondrial
depolarization, possibly paving the way for accelerated NCoR1
removal (Figure 7D). The antagonism between proteasome inhi-
bition and mitochondrial uncoupling was also observed at theitive Promoters
he ZBTB33 motif, a DNA-binding factor that associates with NCoR1.
ed as in Figure 2G). Right: NCoR1 is enriched at degradation sites. Enrichment
enrichment at genes associated with CREB only (Figure 3H). Bars represent
tive ubiquitin peaks (DEG).
that are enriched for the combination of NCoR1, CREB, and degradation peaks
rolled by a repressor (Tet).
clear mitochondrial genes. Black bars represent 5 kbp.
anti-CREB antibodies in the sequence depicted. NCoR1 and CREB associated
N(DC), amutant of NCoR1missing the three RIDs at the C terminus was used in
lane four.
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level of H3K27 acetylation (Figure 7E; p < 0.05, two-sided
Student’s t test).
DISCUSSION
Dynamic regulation of gene expression requires the binding as
well as the removal of transcription factors. To investigate the
latter, we established a method to localize and quantify genomic
sites of protein turnover. We focused on ubiquitination as the
initial ‘‘kiss of death’’ to identify DNA elements that correlate
with proteolysis. Our data suggest that DNA-associated degra-
dation occurs at genes with high activity, and we propose that
the majority of DNA-linked proteolysis affects transcriptional
regulators, in line with previous work (Salghetti et al., 2000).
Furthermore, we could exclude RNA polymerase II itself as a
major substrate of degradation (data not shown).
Our data demonstrate that protein turnover is enriched at
CREB-occupied promoters. We propose that this is caused by
degradation of the associated corepressor NCoR1. Proteolysis
of NCoR1 is a well-documented mechanism that controls the
switch from repression to activation in nuclear hormone receptor
target genes (Perissi et al., 2010). NCoR1 depletion increases
insulin signaling, metabolic efficiency, and muscle size, and
NCoR1 inhibition may provide treatment options for type II dia-
betes and sarcopenia (Li et al., 2011; Yamamoto et al., 2011).
CREB activation and NCoR1 depletion both stimulate mitochon-
drial activity and biogenesis in muscle cells (Wu et al., 2006;
Yamamoto et al., 2011). In addition, the kinase AKT can simulta-
neously activate CREB (Du and Montminy, 1998) and inactivate
NCoR1 (Perissi et al., 2010), suggesting antagonism between
both. Consistent with this notion, we provide here evidence for
an immediate repression of CREB by NCoR1. Both proteins
physically interact either directly or via cofactors at promoters
that are predominantly TATA-less (Conkright et al., 2003) (Fig-Figure 5. NCoR1 and Siah2 Antagonistically Regulate Mitochondrial C
(A) 3T3-L1 cells were transducedwith NCoR1-specific or scrambled shRNA. CREB
(dotted curve) are derepressed following NCoR1 depletion (black arrow).
(B) Sensitivity plot of 1,274 mitochondrial genes to NCoR1 knockdown (blue cu
(black curve) compared to scrambled shRNA.
(C) Derepression by NCoR1 knockdown compared to double knockdown does no
nuclear mitochondrial genes (gray curve).
(D) Expression of 1,274mitochondrial genes following lactacystin treatment. NCoR
compared to untreated cells with the respective shRNA constructs). Sensitivity
regression curve (dotted line) is diverging from the diagonal (black line).
(E) ChIP of 3FLAG-NCoR1 and endogenous CREB shows binding to the pro
proteasome inhibition (analysis by qPCR; p < 0.03).
(F) Expression of genes based on RT-qPCR in cells transduced with scramble
Expression is significantly reduced by lactacystin and Siah2 knockdown and incre
had no effect.
(G) qPCR of three promoters after sequential ChIP of 3FLAG-NCoR1 in the first
(H) Followed by precipitation of polyubiquitin in the second round. Cells were treate
Siah2.
(I) Gene expression following CREB knockdown. CREB target genes (blue)—espe
are derepressed (black arrow; p = 9.42 3 1024).
(J) ChIP of endogenous NCoR1 shows depletion following CREB knockdown (p
(K) CREB target genes are upregulated following CREB knockdown (p < 0.05).
(L) Levels of Ser133-phosphorylated CREB are not affected by NCoR1 or Siah2
(M) Acetylation of H3K27 at the promoters of AKAP1,MRPS18b, and NDUFV1 is i
(p < 0.005). All bars represent mean ± SD.
See also Figures S4 and S5.ure S7B). CREB-bound genes that are repressed by the protea-
some are induced by the cAMP-generating drug forskolin
(Figures S7C and S7D), suggesting they are not fully activated
at steady state. Combined, these results support a model by
which CREB activity can be modulated at three levels: repres-
sion by NCoR1, derepression by elimination of NCoR1, and full
activation by removal of NCoR1 and phosphorylation of CREB.
It remains to be determined whether derepression and activation
occur independently under physiological conditions.
Ubiquitination of NCoR1 is triggered by the ligase Siah2
(Zhang et al., 1998), but substrate recognition requires addi-
tional factors such as F-box-like/WD40-containing proteins
(Perissi et al., 2004). Siah2 also directly regulates mitochondrial
proteins under hypoxic conditions (Carlucci et al., 2008; Kim
et al., 2011a). We grew cells under ambient oxygen, and our
experimental design probed for the expression of nuclear
genes as primary readout. The fact that a combined knock-
down with NCoR1 rescued the effects of Siah2 deficiency alone
suggests that the main impact of Siah2 on mitochondrial
activity under normal oxygen occurs in the nucleus. In addition,
Siah2 regulates NCoR1 abundance at target promoters, and we
provide evidence for antagonistic control of H3K27 acetylation
at mitochondrial genes by these two factors (Figures 5B, 5F,
5G, and 5M). However, it is intriguing that hypoxia, as well as
mitochondrial dysfunction under normoxic conditions (FCCP
treatment), induces Siah2 (Nakayama et al., 2004). Under low
oxygen, the E3 ligase attenuates oxidative phosphorylation by
eliminating mitochondrial proteins and stabilizing the HIF
pathway, an obvious response to the environment. Under nor-
moxic conditions, we observed an opposite effect, in which
Siah2 stimulates mitochondrial activity. Binding of Siah2 to sub-
strate is mediated through WD40 domain-containing proteins.
Genes encoding these modules are among the most upregu-
lated following FCCP treatment (p = 1.6 3 107, Fisher’s exactREB Target Genes
target genes (black curve) andCREB-associated nuclearmitochondrial genes
rve), Siah2 knockdown (orange curve), and Siah2/NCoR1 double knockdown
t apply to the entire genome (black curve) but to specific gene entities such as
1 single as well as Siah2/NCoR1 double knockdown cells show repression (<1
to inhibition is greater in cells with NCoR1 depletion only (x axis), and the
moters of AKAP1, MRPS18b, and NDUFV1. NCoR1 accumulates following
d shRNA (‘‘3T3L1’’) or cells depleted for NCoR1, Siah2, and Siah2/NCoR1.
ased by NCoR1 knockdown (p < 0.032). Combined Siah2/NCoR1 knockdown
round.
d with lactacystin and either transducedwith scrambled shRNA or depleted for
cially those co-overlapping with NCoR1 binding and degradation peaks (red)—
< 0.04).
knockdown.
ncreased in NCoR1 knockdown cells and decreased in Siah2 knockdown cells
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Figure 6. NCoR1 Functionally Restrains Mitochondria
(A) FACS plots of 3T3-L1 cells transduced with shRNA constructs for NCoR1 and Siah2 or scrambled control (‘‘neg. ctrl.’’). The top panel shows staining to assess
mitochondrial number, and the bottom panel show staining to quantify Dcm.
(B) Confocal microscopy of scrambled shRNA-transduced 3T3-L1 cells and NCoR1 and Siah2/NCoR1 knockdown cells. Cells were stained with JC-1, which
forms red fluorescent aggregates in hyperpolarized mitochondria.
(C) High-resolution microscopy of JC-1-labeled NCoR1 knockdown (top) and Siah2/NCoR1 knockdown cells (bottom).
See also Figure S6.test; data not shown). It is therefore conceivable that Siah2
could adjust its function by recruiting different recognition mod-
ules and promoting degradation of distinct substrates in depen-1392 Cell 155, 1380–1395, December 5, 2013 ª2013 Elsevier Inc.dence of the metabolic milieu. Under this assumption, one
might expect that hypoxia induces stabilization of NCoR1,
despite upregulation of Siah2. Also, Siah2 is phosphorylated
Figure 7. Mitochondrial Dysfunction Accelerates NCoR1 Degradation
(A) Genome-wide expression changes following treatment with FCCP or Siah2 depletion. The red gate signifies genes that are upregulated by FCCP and
downregulated by Siah2 knockdown.
(B) Mitochondrial genes (1,274) are stimulated by treatment with FCCP (blue curve) and repressed by lactacystin (red curve; p < 0.0004) but are not significantly
altered by combined treatment.
(C) ChIP of endogenous NCoR1 shows elimination from promoters following FCCP treatment (analysis by qPCR; p < 0.027). Promoter occupancy in Siah2
knockdown cells is higher (p < 0.01), and FCCP does not remove NCoR1 from promoters in these cells.
(D) Upregulation of AKAP1, MRPS18b, and NDUFV1 following FCCP treatment (p < 0.02). No significant upregulation is seen in Siah2 knockdown cells.
(E) Acetylation levels of H3K27 at indicated promoters following FCCP or lactacystin treatment. FCCP increases and lactacystin decreases acetylation (p < 0.05).
All bars represent mean ± SD.
See also Figure S7.under hypoxia, which facilitates its nuclear export (Khurana
et al., 2006).
Our inability to detect binding of endogenous NCoR1 to
CREB in the absence of crosslinking may reflect the short
duration of this interaction at steady state. Further studies are
needed to examine how different physiological conditions
impact the NCoR1/CREB complex and how Siah2 achieves
specificity for the removal of NCoR1 in a subset of genes, a
phenomenon that was recently exemplified by the role of this
E3 ligase in gene-selective androgen receptor regulation (Qi
et al., 2013).
As an adaptor molecule, NCoR1 is involved in HDAC recruit-
ment (You et al., 2013) and other mechanisms of transcriptional
control (Zhou et al., 2008). It is surprising that a cell would invest
in the continuous destruction of a large protein such as NCoR1,
whose synthesis is so ATP consuming. This costly mechanism
may provide a suitable feedback between the nucleus and mito-
chondria when energy deficiency translates into diminished
corepressor levels, which then releases mitochondrial genes to
increase ATP production.The examination of degradation sites for transcription factor
motifs revealed more than 80 candidates, including nuclear
hormone receptors (Perissi et al., 2010). The most prominent
motifs within this family belong to the glucocorticoid receptor
GCR/NR3C1, the thyroid hormone receptor THRA, and the reti-
noic acid receptor RARG (p < 0.0006, Z test). Therefore, our re-
sults do not contradict earlier reports on proteasomal regulation
of nuclear hormone receptors.
NCoR1 has been shown to repress several transcription
factors (Ghisletti et al., 2009), in part by recruitment through
non-DNA-bound nuclear hormone receptors (Pascual et al.,
2005). It is therefore conceivable that a nuclear hormone recep-
tor forms a complex with CREB and NCoR1. However, we have
no data to support such a connection because NCoR1 does not
require the receptor interacting domain for association with
CREB (Figure 4H).
Our method favors the detection of DNA regions with dynamic
protein turnover. It is very well possible that the majority of
NCoR1 at steady state binds to nuclear hormone receptors,
but it is the particularly short-lived interaction with CREB thatCell 155, 1380–1395, December 5, 2013 ª2013 Elsevier Inc. 1393
we identified. There are intriguing parallels between nuclear
hormone receptors and CREB. Both recruit coactivators upon
stimulation and are involved in homeostasis and metabolic
adaptation (Altarejos and Montminy, 2011). The parallel that
has been less explored is that of a corepressor. We propose
that NCoR1 dampens CREB target genes, and its constant
elimination by the ubiquitin-proteasome system is required to
maintain gene expression. Given the rapid and reversible nature
of CREB activation and its role as an integrator of environmental
signals (Altarejos and Montminy, 2011), it would be consistent
that NCoR1 degradation is particularly high at metabolic CREB
target promoters.
In summary, we present a functional annotation of DNA-linked
protein degradation, offering mechanistic insights into how the
UPS regulates global gene expression. Our methodology pro-
vides a framework for future studies to dissect the precise role
of individual enzymes of the UPS in DNA-associated degrada-
tion and to investigate differences between various cell types.
EXPERIMENTAL PROCEDURES
Full descriptions of experimental procedures as well as gene expression
values, ChIP-on-chip results, gene annotations, and ChIP-seq maps are
included in the Extended Experimental Procedures and in Tables S1 and S2.
Cell Culture
3T3-L1 cells were grown in DMEM/10%FCS (37C, 5%CO2). The proteasome
was inhibited with lactacystin for 3 (ChIPs) or 6 hr (expression analyses).
Gene Expression
Expression was measured with Affymetrix Mouse Gene 1.0 ST arrays.
Libraries were constructed using oligo-dT in combination with random hex-
amer priming. SYBR-Green based RT-qPCR was performed with transcript-
specific reverse transcription.
ChIP-Seq and Data Analyses
We used M2 anti-FLAG or protein-specific antibodies for ChIP. DNA was
prepared according to Illumina’s protocols for single-end sequencing (HiSeq
2000) and mapped to genome mm9. ChIP-seq peaks were called with
MACS1.4, and motifs were detected with SeqPos (2 kb window). GO analyses
were conducted with DAVID (Huang da et al., 2009). Chromatin states are
based on GSE20752 (Mikkelsen et al., 2010), and the genomic distribution of
NCoR1 is based on ERR103444 (Raghav et al., 2012). Unless indicated other-
wise, all statistical tests are based on the two-sided Wilcoxon rank-sum test
with Bonferroni correction.
ACCESSION NUMBERS
Sequencing data are available at the Gene Expression Omnibus (GSE33821)
under accession numbers GSM838021, GSM838022, GSM838023,
GSM838024, GSM841627, GSM1095377, GSM1095378, GSM1095379,
GSM1095380, GSM1095381, GSM1095382, and GSM1095383.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and two tables and can be foundwith this article online at http://dx.doi.
org/10.1016/j.cell.2013.11.016.
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